youtube_live
Q2 2027 earnings • released • EPS beat +8.55% • Revenue beat +2.66%
See resultschevron_right
LALPATHLAB:NSE
Dr. Lal PathLabs Ltd
₹2,045.00
arrow_upward
+6.20%(+119.30) 1D
Nov 4, 3:30:02 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LALPATHLAB...
Open
₹1,934.10
High
₹2,049.00
Low
₹1,901.00
Mkt. cap
341.84B
Avg. vol.
271.33K
Volume
735.42K
Dividend
0.78%
Quarterly dividend
₹4.00
Ex-dividend date
Jun 25, 2026
P/E ratio
63.12
52-wk high
₹2,049.00
52-wk low
₹1,272.60
EPS
₹32.40
Shares outstanding
83.34M
No. of employees
5K
Open
₹1,934.10
High
₹2,049.00
Low
₹1,901.00
Mkt. cap
341.84B
Avg. vol.
271.33K
Volume
735.42K
Dividend
0.78%
Quarterly dividend
₹4.00
Ex-dividend date
Jun 25, 2026
P/E ratio
63.12
52-wk high
₹2,049.00
52-wk low
₹1,272.60
EPS
₹32.40
Shares outstanding
83.34M
No. of employees
5K
News stories
From web sources and news partners
Investing.com
·
9 hours ago
Dr. Lal PathLabs Q2 FY27 slides: 19.6% revenue growth, highest in 5 years
Investing.com
·
9 hours ago
Earnings call transcript: Dr. Lal PathLabs posts strong Q2 2027 growth
Yahoo Finance
·
13 hours ago
India's Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand
TradingView
·
14 hours ago
LALPATHLAB: Volume-led Q2 growth lifted revenue 19.6% and strengthened margins
Profile
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia
About Dr. Lal PathLabs Ltd